Melagatran and ximelagatran. No real simplification of anticoagulant therapy

Prescrire International

Volumn 14, Issue 78, 2005, Pages 127-132

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDOTE; ANTIVITAMIN K; ARGATROBAN; CLOPIDOGREL; DALTEPARIN; DESULFATOHIRUDIN; DEXTRO PHENYLALANYLPROLYLARGINYL CHLOROMETHYL KETONE; DIPYRIDAMOLE; ENOXAPARIN; ERYTHROMYCIN; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; SULFINPYRAZONE; TICLOPIDINE; WARFARIN; XIMELAGATRAN; ANTICOAGULANT AGENT; AZETIDINE DERIVATIVE; DRUG DERIVATIVE; GLYCINE;

AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING TEST; CAUSE OF DEATH; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG MARKETING; DRUG MECHANISM; DRUG OVERDOSE; EMBRYOPATHY; ENZYME DEFECT; FRANCE; HEART INFARCTION; HUMAN; KIDNEY FAILURE; KNEE ARTHROPLASTY; LUNG EMBOLISM; NAUSEA AND VOMITING; NONHUMAN; OBESITY; SYMPTOMATOLOGY; TOTAL HIP PROSTHESIS; UNDERWEIGHT; VENOUS THROMBOEMBOLISM; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; HIP ARTHROPLASTY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VEIN THROMBOSIS;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; AZETIDINES; FIBRINOLYTIC AGENTS; GLYCINE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 22144479420     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Prescrire Editorial Staff "Preventing pulmonary embolism" Prescrire Int 2003; 12 (65): 111.
2. Weitz JI and Hirsch J "New antithrombotic agents" Chest 1998; 114 (suppl.): 715-727.
3. o. Thromboprophylaxie: pas mieux que les HBPM" Rev Prescrire 1999; 19 (200): 742-744.
4. Bura-Riviere A and Fiessinger JN "Les nouveaux anticoagulants dans la maladie thromboembolique veineuse" Rev Med Interne 2003; 24: 738-744.
5. "Argatroban". In: "Martindale The Complete Drug Reference" 34th, ed, The Pharmaceutical Press, London 2005: 864-865.
6. "Argatroban". In: "Physicians' Desk Reference" 59th ed, Thomson, Montvale 2004: 1431-1435.
7. Prescrire Rédaction "Pourquoi récuser les critères combinés dans les essais cliniques du fondaparinux?" Rev Prescrire 2003; 23 (239): 396-2.
8. Colwell CW et al. "Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study" J Thromb Haemost 2003; 1: 2119-2130.
9. Eriksson BI et al. "Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee remplacement: the METHRO III study" Thromb Haemost 2003; 89: 288-296.
10. Eriksson BI et al. "Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial" Lancet 2002; 360: 1441-1447.
11. Eriksson BI et al. "The direct thrombin inhibitor melagatran followed by oral ximelagatran, compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study" J Thromb and Haemost 2003; 1: 2490-2496.
12. Eriksson BI et al. "A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I" Thromb Haemost 2002; 87: 231-237.
13. Heit JA et al. "Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement. A phase 2 dose-finding study" Arch Intern Med 2001; 161: 2215-2221.
14. Francis CW et al. "Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement" N Engl J Med 2003; 349 (18): 1703-1712.
15. Colwell C et al. "Randomized, double-blind comparison of ximelagatran, an oral direct thrombin inhibitor, and warfarin to prevent venous thromboembolism (VTE) after total knee replacement (TKR): EXULT B" Blood 2003; 102 (11): abstr 39 (1 page).
16. Francis CW et al. "Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized double-blind trial" Ann Intern Med 2002; 137: 648-655.
17. US Food and Drug Administration - Center for Drug Evaluation and Research "Clinical review for NDA 21-686" 5 August 2004: 194 pages.
18. US Food and Drug Administration - Center for Drug Evaluation and Research "Cardiovascular and renal drugs advisory committee" 10 September 2004: 414 pages.
19. Prescrire Editorial Staff "Choosing an anticoagulant during pregnancy" Prescrire Int 2001; 10 (55): 153-155.
20. "US FDA rejects Exanta" Scrip 2004; (2995): 21.